Evidence map›Paper›PMID 39737172›Full record

ArticleFrontiers in immunology2024

Soluble CD52 mediates immune suppression by human seminal fluid.

Leonard C Harrison, Natalie L Stone, Esther Bandala-Sanchez, Nicholas D Huntington, Robert I McLachlan, Jai Rautela, Moira K O'Bryan

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leonard C HarrisonPopulation Heath and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Natalie L StonePopulation Heath and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Esther Bandala-SanchezPopulation Heath and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Nicholas D HuntingtonPopulation Heath and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Robert I McLachlanHudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.
Jai RautelaPopulation Heath and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Moira K O'BryanSchool of Biosciences and Bio21 Molecular Science and Biotechnology Institute, Faculty of Science, The University of Melbourne, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seminal fluid provides for the carriage and nutrition of sperm, but also modulates immunity to prevent allo-rejection of sperm by the female. Immune suppression by seminal fluid has been associated with extracellular vesicles, originally termed prostasomes, which contain CD52, a glycosylated glycophosphoinositol-anchored peptide released from testicular epithelial cells. Previously, we reported that human T cell-derived CD52, bound to the danger-associated molecular pattern protein, high mobility group box 1 (HMGB1), suppresses T cell function via the inhibitory sialic acid-binding immunoglobulin-like lectin-10 (Siglec-10) receptor. Here we show that human seminal fluid contains high concentrations of CD52 complexed with HMGB1, which mediates T cell suppression indirectly via Siglec-7 on antigen-presenting cells. Proliferation of natural killer (NK) cells, which express Siglec-7 and play a key role in the immune defence of the uterus, was directly suppressed by seminal fluid CD52. These findings elucidate a critical function of seminal fluid to suppress cellular immunity and facilitate reproduction.

Indexed as

CD52 AntigenKiller Cells, NaturalSemenAntigens, Differentiation, MyelomonocyticFemaleHMGB1 ProteinHumansImmune ToleranceLectinsMaleT-LymphocytesAntigens, Differentiation, MyelomonocyticCD52 AntigenCD52 protein, humanHMGB1 ProteinHMGB1 protein, humanLectinsSIGLEC7 protein, humanCD52HMGB1NK cellseminal fluidSiglec-7T cell

Identifiers

PMID39737172
PMCPMC11682959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.